IRIS
FARINA, NICOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.602
AS - Asia 1.017
NA - Nord America 1.014
SA - Sud America 136
AF - Africa 14
AN - Antartide 1
Totale 3.784
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 962
RU - Federazione Russa 782
CN - Cina 369
SG - Singapore 357
RO - Romania 264
IT - Italia 180
SE - Svezia 115
BR - Brasile 114
HK - Hong Kong 90
DE - Germania 78
VN - Vietnam 73
FR - Francia 54
GB - Regno Unito 41
CA - Canada 36
BD - Bangladesh 35
FI - Finlandia 26
IN - India 25
NL - Olanda 16
MX - Messico 13
PL - Polonia 12
JP - Giappone 11
AR - Argentina 10
IQ - Iraq 9
AT - Austria 8
PH - Filippine 8
TR - Turchia 7
ZA - Sudafrica 7
ID - Indonesia 6
IE - Irlanda 6
EG - Egitto 5
LT - Lituania 5
CO - Colombia 4
ES - Italia 4
UA - Ucraina 4
NP - Nepal 3
PK - Pakistan 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
AZ - Azerbaigian 2
BE - Belgio 2
IR - Iran 2
MD - Moldavia 2
PY - Paraguay 2
SA - Arabia Saudita 2
UZ - Uzbekistan 2
AQ - Antartide 1
BG - Bulgaria 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
GT - Guatemala 1
HR - Croazia 1
IL - Israele 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
KH - Cambogia 1
KR - Corea 1
KZ - Kazakistan 1
LB - Libano 1
LV - Lettonia 1
MA - Marocco 1
MN - Mongolia 1
MY - Malesia 1
PE - Perù 1
TH - Thailandia 1
UY - Uruguay 1
Totale 3.784
Salva come PNG Salva come JPEG
Città #
Dallas 217
Singapore 186
Moscow 154
Ashburn 132
San Jose 120
Hong Kong 88
Shanghai 73
Beijing 62
Munich 47
Milan 44
New York 42
Hefei 36
Ho Chi Minh City 32
Lauterbourg 32
Los Angeles 32
Lawrence 20
Princeton 20
Boardman 19
Orem 19
Helsinki 17
Rome 17
São Paulo 14
Atlanta 13
Montreal 13
Santa Clara 11
Warsaw 11
Hanoi 10
Toronto 10
Amsterdam 9
Chicago 9
Houston 9
Nuremberg 9
Pietra Ligure 8
Brooklyn 7
Cesano Boscone 7
Chennai 7
Guangzhou 7
London 7
Manchester 7
Tokyo 7
Frankfurt am Main 6
Johannesburg 6
Turku 6
Boston 5
Denver 5
Mexico City 5
New Delhi 5
Shenzhen 5
Stockholm 5
Ancona 4
Ankara 4
Pune 4
Quezon City 4
Seattle 4
The Dalles 4
Baghdad 3
Baie-D'Urfé 3
Ballincollig 3
Barnet 3
Bexley 3
Buffalo 3
Cairo 3
City of London 3
Council Bluffs 3
Da Nang 3
Dublin 3
Falkenstein 3
Genoa 3
Jundiaí 3
Las Vegas 3
Mumbai 3
Newark 3
Osimo 3
Paris 3
Poli 3
Poplar 3
Rio de Janeiro 3
Salvador 3
San Antonio 3
San Giuliano 3
Vittoria 3
York 3
Aobadai 2
Assago 2
Bauru 2
Belo Horizonte 2
Bismarck 2
Bologna 2
Bosco Chiesanuova 2
Brescia 2
Campinas 2
Castel Mella 2
Concórdia 2
Dalmine 2
Dhaka 2
Diadema 2
Fermo 2
Florence 2
Ghent 2
Hangzhou 2
Totale 1.773
Salva come PNG Salva come JPEG
Nome #
Autoantibody positivity predicts severity of rheumatic immune-related adverse events to immune-checkpoint inhibitors 388
EA4HP24-LYWS-293 An indolent EBV-related clonal T-cell proliferation presenting as chronic rhinosinusitis 193
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 168
Biobanking for COVID-19 research 145
Post-traumatic stress disorder in patients with systemic lupus erythematosus heavily affects quality of life. A cross-sectional web survey-based study 123
Beyond Neuropsychiatric Manifestations of Systemic Lupus Erythematosus: Focus on Post-traumatic Stress Disorder and Alexithymia 122
Tocilizumab for the treatment of immune-related adverse events: a systematic literature review and a multicentre case series 116
A novel disorder involving dyshematopoiesis, inflammation, and HLH due to aberrant CDC42 function 115
Effectiveness of a two-year tapered course of tocilizumab in patients with giant cell arteritis: A single-centre prospective study 113
Drug retention rates of biological agents in adult onset Still's disease 107
COVID-19: Pharmacology and kinetics of viral clearance 104
GM-CSF blockade with mavrilimumab in severe COVID-19 pneumonia and systemic hyperinflammation: a single-centre, prospective cohort study 103
Giant cell arteritis: Update on clinical manifestations, diagnosis, and management 100
Canakinumab injection for the treatment of active Still’s disease, including adult-onset Still’s disease 100
Anakinra for the Treatment of Antisynthetase Syndrome: A Monocentric Case Series and a Systematic Literature Review 99
Drug development and novel therapeutics to ensure a personalized approach in the treatment of systemic sclerosis 97
DRUG RETENTION RATES OF BIOLOGICAL AGENTS IN ADULT ONSET STILL'S DISEASE IN THE PRE-CANAKINUMAB ERA 97
Myocarditis as a manifestation of Erdheim–Chester Disease: successful use of anti- IL1 and BRAF inhibitor combination therapy 94
Catastrophic antiphospholipid syndrome presenting with aortic barrage: case report and review of the literature 94
Efficacy and improved tolerability of combination therapy with interleukin-1 blockade and MAPK pathway inhibitors for the treatment of Erdheim-Chester disease 92
Interleukin 1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study 92
Cardiac Sarcoidosis: Clinical Insights, Diagnosis, and Management Strategies 90
Obesity and its role in the management of rheumatoid and psoriatic arthritis 90
Effectiveness and safety of mycophenolate mofetil and rituximab combination therapy for immune idiopathic myopathies 88
Current treatment options and safety considerations when treating adult-onset Still’s disease 86
The Role of the Multidisciplinary Health Care Team in the Management of Patients with Systemic Sclerosis 79
Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study 69
POS0726 POST-TRAUMATIC STRESS DISORDER AND QUALITY OF LIFE IN SYSTEMIC LUPUS ERYTHEMATOSUS. A CROSS SECTIONAL WEB SURVEY-BASED STUDY 69
Impact of the COVID-19 pandemic in patients with systemic lupus erythematosus throughout one year 68
Presenting features and outcomes of cranial-limited and large-vessel giant cell arteritis: a retrospective cohort study 65
Long-Term Clinical Outcome in Systemic Lupus Erythematosus Patients Followed for More Than 20 Years: The Milan Systemic Lupus Erythematosus Consortium (SMiLE) Cohort 63
Low prevalence of arrhythmias in clinically stable COVID-19 patients 62
Secukinumab is not associated with cancer recurrence or progression in patients with spondyloarthritis and history of neoplastic disease 61
Severe acute respiratory syndrome coronavirus-2-induced flare of systemic sclerosis 59
Loss of circulating CD8+ CD161high T cells in primary progressive multiple sclerosis 58
Repurposing of Biologic and Targeted Synthetic Anti-Rheumatic Drugs in COVID-19 and Hyper-Inflammation: A Comprehensive Review of Available and Emerging Evidence at the Peak of the Pandemic 57
Interleukin 6 inhibition in severe COVID-19: Another piece of the puzzle 52
Retention rates of different Janus kinase inhibitors in rheumatoid arthritis: experience from a large monocentric cohort 51
Patients' experience and tolerability with canakinumab and anakinra for the treatment of adult-onset Still's disease 45
Totale 3.874
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.945
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.945
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211 0 0 0 0 0 0 0 0 0 0 0 1
2021/202248 1 0 12 14 2 0 1 1 6 7 0 4
2022/2023216 50 43 16 6 12 25 20 25 4 2 6 7
2023/2024242 11 26 32 27 26 28 14 27 0 4 13 34
2024/2025909 56 15 21 28 42 50 358 66 92 36 47 98
2025/20262.430 169 167 183 286 181 66 203 197 687 148 68 75
Totale 3.874